Home › Funds › Pivotal bioVenture Partners Investment Advisor LLC › BIOA

Pivotal bioVenture Partners Investment Advisor LLC position in BIOA

BIOAGE LABS INC · Health Care

Pivotal bioVenture Partners Investment Advisor LLC reported holding 653,374 shares of BIOA (BIOAGE LABS INC) in its Q3 2026 13F filing — a position valued at US$4.6M, representing 1.89% of its reported portfolio and ranking #13 among its reported holdings. Pivotal bioVenture Partners Investment Advisor LLC has disclosed BIOA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)653.37K sh
Reported value held$4.63M
Portfolio Weight1.89%
First reportedQ3 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Pivotal bioVenture Partners Investment Advisor LLC's BIOA position evolved

Pivotal bioVenture Partners Investment Advisor LLC first disclosed a stake in BIOA in Q3 2024 at 527,647 shares (US$11.0M). The position peaked in Q2 2026 at 653,374 shares, worth US$16.0M. Across 9 filings, Pivotal bioVenture Partners Investment Advisor LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 653,374 shares valued at US$4.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 527.65K $10.98M New
Q4 2024 653.37K $3.78M Add
Q1 2025 653.37K $2.46M Hold
Q2 2025 653.37K $2.70M Hold
Q3 2025 653.37K $3.84M Hold
Q4 2025 653.37K $8.64M Hold
Q1 2026 653.37K $11.43M Hold
Q2 2026 653.37K $16.01M Hold
Q3 2026 653.37K $4.63M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIOA and 13F data

BIOA (BIOAGE LABS INC) is a Health Care company. 61 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIOA

All BIOA fund holders →

FAQ

How long has Pivotal bioVenture Partners Investment Advisor LLC held BIOA?

Pivotal bioVenture Partners Investment Advisor LLC has disclosed BIOA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Pivotal bioVenture Partners Investment Advisor LLC's current position in BIOA?

As of Q3 2026, Pivotal bioVenture Partners Investment Advisor LLC holds 653.37K shares of BIOA (BIOAGE LABS INC), valued at $4.63M, representing 1.89% of its reported portfolio and ranking #13.

Has Pivotal bioVenture Partners Investment Advisor LLC been buying or selling BIOA?

In the latest 13F filing (Q3 2026), Pivotal bioVenture Partners Investment Advisor LLC held unchanged its position in BIOA. The position peaked in Q2 2026 at 653.37K shares.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.